[Ileocolitis in an immunocompromised patient. Crohn's disease or an infection?]

Ned Tijdschr Geneeskd. 2020 Nov 23:164:D4813.
[Article in Dutch]

Abstract

Background: Histoplasma capsulatum is an endemic fungus in especially tropical areas. While mostly asymptomatic, histoplasmosis can be life-threatening in immunocompromised patients.

Case description: A 60-year-old woman of Suriname origin, with a history of renal transplantation and use of mycophenolate mofetil and prednisone, presented with abdominal pain and diarrhea. Colonoscopy revealed ulcerative ileocolitis and biopsy showed active granulomatous inflammation. Morbus Crohn was considered the most plausible diagnosis after ruling out several infectious and pharmacological causes. Despite prednisone treatment, symptoms persisted and infliximab was initiated. The patient developed constitutional symptoms and radiological examination revealed disseminated granulomatous disease. Liver biopsy and re-evaluation of previous intestinal histopathology confirmed suspected histoplasmosis.

Conclusion: Histoplasmosis should be considered in immunocompromised patients with ileocolitis who have been in endemic regions (South America). Physicians need to assess the risk of previous exposure to histoplasmosis before starting anti-TNF-α therapy.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Pain / diagnosis
  • Abdominal Pain / etiology
  • Biopsy
  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / etiology
  • Colonoscopy / methods
  • Crohn Disease / complications
  • Crohn Disease / diagnosis*
  • Crohn Disease / drug therapy
  • Crohn Disease / pathology
  • Diarrhea / diagnosis
  • Diarrhea / etiology
  • Female
  • Granuloma / diagnosis
  • Granuloma / etiology
  • Histoplasma*
  • Histoplasmosis / diagnosis*
  • Histoplasmosis / drug therapy
  • Histoplasmosis / microbiology
  • Histoplasmosis / pathology
  • Humans
  • Immunocompromised Host*
  • Infliximab / therapeutic use
  • Intestines / microbiology*
  • Intestines / pathology
  • Middle Aged
  • Prednisone / therapeutic use
  • South America
  • Suriname
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Prednisone